Abstract
To explore the role of chronic inflammation inherent to autoimmune diseases in the development of subclinical atherosclerosis and arterial stiffness, this study recruited two population-based samples of individuals with and without autoimmune disease (ratio 1:5) matched by age, sex, and education level and with a longstanding (≥6 years) diagnosis of autoimmune disease. Common carotid intima-media thickness (IMT) and arterial distensibility and compliance were assessed with carotid ultrasound. Multivariable linear and logistic regression models were adjusted for 10-year cardiovascular risk. In total, 546 individuals with and without autoimmune diseases (91 and 455, respectively) were included. The mean age was 66 years (standard deviation 12), and 240 (43.9%) were women. Arterial stiffness did not differ according to the presence of autoimmune diseases. In men, the diagnosis of autoimmune diseases significantly increased common carotid IMT [beta-coefficient (95% confidence interval): 0.058 (0.009; 0.108); p value = 0.022] and the percentage with IMT ≥ 75th percentile [1.012 (0.145; 1.880); p value = 0.022]. Women without autoimmune disease were more likely to have IMT ≥ the 75th percentile [−2.181 (−4.214; −0.149); p value = 0.035], but the analysis of IMT as a continuous variable did not yield significant results. In conclusion, subclinical carotid atherosclerosis, but not arterial stiffness, was more common in men with autoimmune diseases. Women did not show significant differences in any of these carotid features. Sex was an effect modifier in the association between common carotid IMT values and the diagnosis of autoimmune diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
30 April 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41440-021-00664-8
References
World Health Statistics. Monograph on the internet. Geneva: World Health Organization; 2011. https://www.who.int/data/gho/data/themes/topics/noncommunicable-diseases.
Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57:1511–22. https://doi.org/10.1016/j.jacc.2010.12.017.
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N. Engl J Med. 2005;352:1685–1695. https://doi.org/10.1056/NEJMra043430.
Baena-Díez JM, Garcia-Gil M, Comas-Cufí M, Ramos R, Prieto-Alhambra D, Salvador-González B, et al. Association between chronic immune-mediated inflammatory diseases and cardiovascular risk. Heart. 2018;104:119–126. https://doi.org/10.1136/heartjnl-2017-311279.
Dalbeni A, Giollo A, Bevilacqua M, Cioffi G, Tagetti A, Cattazzo F, et al. Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients. Hypertens Res. 2020;43:922–8. https://doi.org/10.1038/s41440-020-0441-1.
Jain S, Khera R, Corrales-Medina VF, Townsend RR, Chirinos JA. Inflammation and arterial stiffness in humans. Atherosclerosis. 2014;237:381–90.
Zanoli L, Briet M, Empana JP, Cunha PG, Mäki-Petäjä KM, Protogerou AD, et al. Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. J Hypertens. 2020;38:1682–98. https://doi.org/10.1097/HJH.0000000000002508.
Agüero F, González-Zobl G, Baena-Díez JM, Dégano IR, Garcia-Gil M, Alzamora MT, et al. Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders. Atherosclerosis. 2015;242:1–7. https://doi.org/10.1016/j.atherosclerosis.2015.06.054.
Grau M, Subirana I, Agis D, Ramos R, Basagaña X, Martí R, et al. Carotid intima-media thickness in the Spanish population: reference ranges and association with cardiovascular risk factors. Rev Esp Cardiol. 2012;65:1086–1093. https://doi.org/10.1016/j.recesp.2012.04.026.
Martí-Lluch R, Garcia-Gil MDM, Camós L, Comas-Cufí M, Elosua-Bayés M, Blanch J, et al. Differences in cardio-ankle vascular index in a general Mediterranean population depending on the presence or absence of metabolic cardiovascular risk factors. Atherosclerosis. 2017;264:29–35. https://doi.org/10.1016/j.atherosclerosis.2017.07.013.
Grau M, Subirana I, Elosua R, Solanas P, Ramos R, Masiá R, et al. Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain. Eur J Cardiovasc Prev Rehabil. 2007;14:653–659. https://doi.org/10.1097/HJR.0b013e3281764429.
Bolíbar B, Fina Avilés F, Morros R, Garcia-Gil Mdel M, Hermosilla E, Ramos R, et al. SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research. Med Clin. 2012;138:617–621. https://doi.org/10.1016/j.medcli.2012.01.020.
Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health. 2007;61:40–47. https://doi.org/10.1136/jech.2005.038505.
de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML, et al. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pr Cardiovasc Med. 2008;5:280–288. https://doi.org/10.1038/ncpcardio1163.
Vila MDM, Remeseiro B, Grau M, Elosua R, Betriu À, Fernandez-Giraldez E, et al. Semantic segmentation with DenseNets for carotid artery ultrasound plaque segmentation and CIMT estimation. Artif Intell Med. 2020;103:101784. https://doi.org/10.1016/j.artmed.2019.101784.
Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34:290–296. https://doi.org/10.1159/000343145.
Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, et al. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens. 2002;15:445–52. https://doi.org/10.1016/s0895-7061(01)02326-3.
Łoboz-Rudnicka M, Jaroch J, Bociąga Z, Rzyczkowska B, Uchmanowicz I, Polański J, et al. Impact of cardiovascular risk factors on carotid intima-media thickness: sex differences. Clin Inter Aging. 2016;11:721–31. https://doi.org/10.2147/CIA.S103521.
DuPont JJ, Kenney RM, Patel AR, Jaffe IZ. Sex differences in mechanisms of arterial stiffness. Br J Pharm. 2019;176:4208–25. https://doi.org/10.1111/bph.14624.
Wang P, Guan SY, Xu SZ, Li HM, Leng RX, Li XP, et al. Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis. Clin Rheumatol. 2016;35:315–23. https://doi.org/10.1007/s10067-015-3130-8.
Henrot P, Foret J, Barnetche T, Lazaro E, Duffau P, Seneschal J, et al. Assessment of subclinical atherosclerosis in systemic lupus erythematosus: a systematic review and meta-analysis. Jt Bone Spine. 2018;85:155–63. https://doi.org/10.1016/j.jbspin.2017.12.009.
Wu GC, Leng RX, Lu Q, Fan YG, Wang DG, Ye DQ. Subclinical atherosclerosis in patients with inflammatory bowel diseases: a systematic review and meta-analysis. Angiology. 2017;68:447–61. https://doi.org/10.1177/0003319716652031.
Bai R, Zhang Y, Liu W, Ma C, Chen X, Yang J, et al. The relationship of ankylosing spondylitis and subclinical atherosclerosis: a systemic review and meta-analysis. Angiology. 2019;70:492–500. https://doi.org/10.1177/0003319718814309.
Balogh E, Pusztai A, Hamar A, Végh E, Szamosi S, Kerekes G, et al. Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis. Clin Immunol. 2019;199:47–51. https://doi.org/10.1016/j.clim.2018.12.011.
Szekanecz Z, Kerekes G, Végh E, Kardos Z, Baráth Z, Tamási L, et al. Autoimmune atherosclerosis in 3D: how it develops, how to diagnose and what to do. Autoimmun Rev. 2016;15:756–69. https://doi.org/10.1016/j.autrev.2016.03.014.
Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76:17–28. https://doi.org/10.1136/annrheumdis-2016-209775.
Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010;69:1269–74. https://doi.org/10.1136/ard.2009.117200.
Coll B, Betriu A, Feinstein SB, Valdivielso JM, Zamorano JL, Fernández E. The role of carotid ultrasound in assessing carotid atherosclerosis in individuals at low-to-intermediate cardiovascular risk. Rev Esp Cardiol. 2013;66:929–34. https://doi.org/10.1016/j.rec.2013.05.030.
Wu TW, Hung CL, Liu CC, Wu YJ, Wang LY, Yeh HI. Associations of cardiovascular risk factors with carotid intima-media thickness in middle-age adults and elders. J Atheroscler Thromb. 2017;24:677–86. https://doi.org/10.5551/jat.37895.
Frerix M, Stegbauer J, Kreuter A, Weiner SM. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events. Arthritis Res Ther. 2014;16:R54. https://doi.org/10.1186/ar4489.
Kurmann RD, Mankad R. Atherosclerotic heart disease in women with autoimmune rheumatologic inflammatory conditions. Can J Cardiol. 2018;34:381–9. https://doi.org/10.1016/j.cjca.2018.01.015.
Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, García-Carrasco M, Munguía-Realpozo P, Etchegaray-Morales I, et al. Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Atherosclerosis. 2020;297:55–63. https://doi.org/10.1016/j.atherosclerosis.2020.01.028.
Ambrosino P, Tasso M, Lupoli R, Di Minno A, Baldassarre D, Tremoli E, et al. Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: a systematic review and meta-analysis of literature studies. Ann Med. 2015;47:457–67. https://doi.org/10.3109/07853890.2015.1068950.
Wang P, Huang L, Xu Q, Xu L, Deng FY, Lei SF. Assessment of aortic stiffness in patients with rheumatoid arthritis using pulse wave velocity: an update meta-analysis. Arch Med Res. 2019;50:401–12. https://doi.org/10.1016/j.arcmed.2019.10.010.
Teixeira R, Vieira MJ, Gonçalves A, Cardim N, Gonçalves L. Ultrasonographic vascular mechanics to assess arterial stiffness: a review. Eur Heart J Cardiovasc Imaging. 2016;17:233–46. https://doi.org/10.1093/ehjci/jev287.
Katakami N, Mita T, Gosho M, Takahara M, Irie Y, Yasuda T, et al. Clinical utility of carotid ultrasonography in the prediction of cardiovascular events in patients with diabetes: a combined analysis of data obtained in five longitudinal studies. J Atheroscler Thromb. 2018;25:1053–1066.
Kokubo Y, Watanabe M, Higashiyama A, Nakao YM, Nakamura F, Miyamoto Y. Impact of intima-media thickness progression in the common carotid arteries on the risk of incident cardiovascular disease in the Suita study. J Am Heart Assoc. 2018;7:e007720. https://doi.org/10.1161/JAHA.117.007720.
Polak JF, O’Leary DH. Carotid intima-media thickness as surrogate for and predictor of CVD. Glob Heart 2016;11:295–312.e3. https://doi.org/10.1016/j.gheart.2016.08.006.
Vila MDM, Remeseiro B, Grau M, Elosua R, Betriu À, Fernandez-Giraldez E, et al. Semantic segmentation with DenseNets for carotid artery ultrasound plaque segmentation and CIMT estimation. Artif Intell Med. 2020;103:101784. https://doi.org/10.1016/j.artmed.2019.101784.
Nagy G, Németh N, Buzás EI. Mechanisms of vascular comorbidity in autoimmune diseases. Curr Opin Rheumatol. 2018;30:197–206. https://doi.org/10.1097/BOR.0000000000000483.
Ramos R, Balló E, Marrugat J, Elosua R, Sala J, Grau M, et al. Validity for use in research on vascular diseases of the SIDIAP (Information System for the Development of Research in Primary Care): the EMMA study. Rev Esp Cardiol. 2012;65:29–37. https://doi.org/10.1016/j.recesp.2011.07.017.
Fina-Aviles F, Medina-Peralta M, Mendez-Boo L, Hermosilla E, Elorza JM, Garcia-Gil M, et al. The descriptive epidemiology of rheumatoid arthritis in Catalonia: a retrospective study using routinely collected data. Clin Rheumatol. 2016;35:751–757. https://doi.org/10.1007/s10067-014-2801-1.
Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A. EPISER Study Group. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology. 2002;41:88–95. https://doi.org/10.1093/rheumatology/41.1.88.
López P, Mozo L, Gutiérrez C, Suárez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus. 2003;12:860–865. https://doi.org/10.1191/0961203303lu469xx.
Saro Gismera C, Riestra Menéndez S, Sánchez Fernández R, Milla Crespo A, Lacort Fernández M, Argüelles Fernández G, et al. Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain. Med Interna. 2003;20:232–238.
Sarabi M, Lind L. Short-term effects of smoking and nicotine chewing gum on endothelium-dependent vasodilation in young healthy habitual smokers. J Cardiovasc Pharm. 2000;35:451–6. https://doi.org/10.1097/00005344-200003000-00016.
Acknowledgements
The authors appreciate the System for the Development of Research in Primary Care (SIDIAP) database access, the expert review on autoimmune diseases by Dr. Albert Escola Campabadal, and revision of the English text by Elaine Lilly PhD.
Funding
Supported by grants from the Instituto de Salud Carlos III FEDER (CP12/03287, CP17/00012), Health Research Fund (FIS 2003/HERMES PI20471, PI070403, ETES: PI07/90415, FIS11/06765) and Principado de Asturias Regional Government (IDI-2018–000176). Partially supported with European Regional Development Fund funds and grants from Spain’s Ministerio de Ciencia, Innovación y Universidades (RTI2018–095232-B-C21) and the Generalitat de Catalunya (2017 SGR 1742).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
We declare that our study complies with the principles of the Declaration of Helsinki and that the locally appointed ethics committee has approved the research protocol
Informed consent
Informed consent was obtained from all recruited subjects.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Vila, M.d.M., Remeseiro, B., Igual, L. et al. Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness?. Hypertens Res 44, 978–987 (2021). https://doi.org/10.1038/s41440-021-00655-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-021-00655-9
Keywords
This article is cited by
-
Dendritic cells as potential initiators of immune-mediated hypertensive disorders
Hypertension Research (2022)